WHAT: A rare genetic disease, while depleting patients of infection-fighting antibodies, may actually protect them from certain severe or recurrent viral infections, reports a National Institutes of Health (NIH) study.
Researchers found that HIV and influenza viruses replicate in the cells of people with congenital disorder of glycosylation type IIb (CDG-IIb) at a much lower rate than in healthy donor cells, creating fewer and less infectious viruses. The study, published in The New England Journal of Medicine, was led by Sergio Rosenzweig, M.D., Ph.D., director of the Primary Immune Deficiency (PID) Clinic at the NIH's National Institute of Allergy and Infectious Diseases (NIAID).
New Use of Statins: Fighting a Deadly Viral Infection
Statins, the well-known blockbuster cholesterol-lowering drugs, may have another use after two Perelman School of Medicine microbiologists found a way to use statins to fight the hantavirus.
Advertisement
In the study, the researchers diagnosed CDG-IIb in two siblings with severe development issues who were referred to the NIAID PID Clinic though the NIH Undiagnosed Diseases Program. CDG-IIb is extremely rare, with only one other case reported. The genetic defect of the disease disrupts glycosylation, or the process of attaching sugars to proteins. As a result, proteins called gamma globulins, which include infection-fighting antibodies, are unstable and persist at low levels in the patients' blood.
Interestingly, some viruses, including HIV and influenza, depend on glycosylation to form protective shields. The researchers showed that these viruses were less able to replicate or create protective shields because of the glycosylation defects in CDG-IIb cells. In comparison, adenovirus, poliovirus and vaccinia virus, which either do not rely on glycosylation or do not form protective shields, replicated normally when added to both CDG-IIb and healthy cells. This study suggests that modulating aspects of host glycosylation may be a strategy to control certain viral infections.
Source: Eurekalert
Source: Eurekalert
Brain Uses Long Distance Signals to Guard Against Viral Infections
The brain is equipped with a wonderful system that prevent viruses from invading and attacking it
Advertisement
 Protein That Helps Control Common Viral Infection Identified by ResearchersA protein has been identified by the Infectious disease specialists at the Johns Hopkins Children's Center, which regulates the body's immune response to cytomegalovirus. | Advertisement
|
Viral Infections Could Become a History
Viruses' protection mechanism from immune systems's efforts to stop infections have been identified by Scientists.
Advertisement
Recommended Readings
Latest Research News
Scientists identified mechanisms governing immune cells, selectively removing troublemakers to reshape skin immunity. Benefits those with psoriasis, vitiligo.
By 2050, an anticipated increase from 494 million cases in 2020 to 1.06 billion people with musculoskeletal disabilities is expected.
Experts consulted by GlobalData anticipate a significant overhaul in the Gaucher disease scenario because of forthcoming gene therapies in development.
Within the seven major markets, 12% to 20% of diagnosed prevalent NASH cases present severe liver damage (stage 4 liver fibrosis), denoting cirrhosis.
Memory deficits in individuals with epilepsy, especially cognitive difficulties, might partially stem from the transient impairments caused by these slow waves.